KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacira BioSciences (PCRX) Other Working Capital Changes (2016 - 2025)

Pacira BioSciences (PCRX) has 16 years of Other Working Capital Changes data on record, last reported at -$12.7 million in Q4 2025.

  • For Q4 2025, Other Working Capital Changes fell 98.45% year-over-year to -$12.7 million; the TTM value through Dec 2025 reached $1.2 million, up 2086.89%, while the annual FY2025 figure was $1.2 million, 2086.89% up from the prior year.
  • Other Working Capital Changes reached -$12.7 million in Q4 2025 per PCRX's latest filing, down from -$4.7 million in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $11.5 million in Q2 2025 and bottomed at -$12.7 million in Q4 2025.
  • Average Other Working Capital Changes over 5 years is $388550.0, with a median of $1.4 million recorded in 2021.
  • Peak YoY movement for Other Working Capital Changes: plummeted 425.84% in 2021, then soared 10600.0% in 2023.
  • A 5-year view of Other Working Capital Changes shows it stood at -$3.8 million in 2021, then skyrocketed by 156.33% to $2.1 million in 2022, then tumbled by 190.24% to -$1.9 million in 2023, then crashed by 232.76% to -$6.4 million in 2024, then crashed by 98.45% to -$12.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for Other Working Capital Changes were -$12.7 million in Q4 2025, -$4.7 million in Q3 2025, and $11.5 million in Q2 2025.